drugset / Trial / NCT02276300
HER2-Peptide Vaccination of Patients With Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
Investigation of peptide vaccination targeting HER2/neu in patients with metastasized breast or gastric cancer with moderate HER2/neu expression.
Timeline
- Start
- 2014-12
- Primary completion
- 2017-07-18
- Completion
- 2018-07-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HER2-Peptid-Vakzine | Vaccine | — | — |
| Background | Cyclophosphamide | Other / unclassified | — | — |
| Background | Imiquimod | Other / unclassified | — | — |
| Background | sargramostim | Protein / enzyme biologic | — | — |